SPON2 and prostate neoplasm: The differential expression observed in the microarray analysis was further validated by qRT-PCR for two candidate secreted biomarkers, SPON2 and MSMB, using RNA extracted from prostate tumor tissues (n = 5) and their matched adjacent normal tissues (n = 5).